Another sign of recovery – local biotech Althea raises venture capital to keep investing in biomarkers and other diagnostics. Althea looks particularly interesting for their work on KRAS oncogenes.
http://www.xconomy.com/san-diego/2009/08/21/altheadx-raising-6m/